BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 33137182)

  • 21. Identification of ADP-Ribose Acceptor Sites on In Vitro Modified Proteins by Liquid Chromatography-Tandem Mass Spectrometry.
    Leutert M; Bilan V; Gehrig P; Hottiger MO
    Methods Mol Biol; 2017; 1608():137-148. PubMed ID: 28695508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subcellular Quantitation of ADP-Ribosylation by High-Content Microscopy.
    Muskalla L; Güldenpfennig A; Hottiger MO
    Methods Mol Biol; 2023; 2609():101-109. PubMed ID: 36515832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein and RNA ADP-ribosylation detection is influenced by sample preparation and reagents used.
    Weixler L; Ikenga NJ; Voorneveld J; Aydin G; Bolte TM; Momoh J; Bütepage M; Golzmann A; Lüscher B; Filippov DV; Žaja R; Feijs KL
    Life Sci Alliance; 2023 Jan; 6(1):. PubMed ID: 36368907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ADPredict: ADP-ribosylation site prediction based on physicochemical and structural descriptors.
    Lo Monte M; Manelfi C; Gemei M; Corda D; Beccari AR
    Bioinformatics; 2018 Aug; 34(15):2566-2574. PubMed ID: 29554239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studying Catabolism of Protein ADP-Ribosylation.
    Palazzo L; James DI; Waddell ID; Ahel I
    Methods Mol Biol; 2017; 1608():415-430. PubMed ID: 28695524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macrodomain Mac1 of SARS-CoV-2 Nonstructural Protein 3 Hydrolyzes Diverse ADP-ribosylated Substrates.
    Chea C; Lee DY; Kato J; Ishiwata-Endo H; Moss J
    bioRxiv; 2023 Feb; ():. PubMed ID: 36945431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of an Inhibitor Screening Assay for Mono-ADP-Ribosyl Hydrolyzing Macrodomains Using AlphaScreen Technology.
    Haikarainen T; Maksimainen MM; Obaji E; Lehtiö L
    SLAS Discov; 2018 Mar; 23(3):255-263. PubMed ID: 29028410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The search for inhibitors of macrodomains for targeting the readers and erasers of mono-ADP-ribosylation.
    Fu W; Yao H; Bütepage M; Zhao Q; Lüscher B; Li J
    Drug Discov Today; 2021 Nov; 26(11):2547-2558. PubMed ID: 34023495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ADP-Ribosylated Peptide Enrichment and Site Identification: The Phosphodiesterase-Based Method.
    Daniels CM; Ong SE; Leung AKL
    Methods Mol Biol; 2017; 1608():79-93. PubMed ID: 28695505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The coronavirus nucleocapsid protein is ADP-ribosylated.
    Grunewald ME; Fehr AR; Athmer J; Perlman S
    Virology; 2018 Apr; 517():62-68. PubMed ID: 29199039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterizing ADP-Ribosylation Sites Using Af1521 Enrichment Coupled to ETD-Based Mass Spectrometry.
    Anagho HA; Elsborg JD; Hendriks IA; Buch-Larsen SC; Nielsen ML
    Methods Mol Biol; 2023; 2609():251-270. PubMed ID: 36515840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous, Quantitative Characterization of Protein ADP-Ribosylation and Protein Phosphorylation in Macrophages.
    Daniels CM; Nuccio A; Kaplan PR; Nita-Lazar A
    Methods Mol Biol; 2020; 2184():145-160. PubMed ID: 32808224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histone ADP-ribosylation in DNA repair, replication and transcription.
    Messner S; Hottiger MO
    Trends Cell Biol; 2011 Sep; 21(9):534-42. PubMed ID: 21741840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ADP-ribose-specific chromatin-affinity purification for investigating genome-wide or locus-specific chromatin ADP-ribosylation.
    Bisceglie L; Bartolomei G; Hottiger MO
    Nat Protoc; 2017 Sep; 12(9):1951-1961. PubMed ID: 28837130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disruption of Macrodomain Protein SCO6735 Increases Antibiotic Production in Streptomyces coelicolor.
    Lalić J; Posavec Marjanović M; Palazzo L; Perina D; Sabljić I; Žaja R; Colby T; Pleše B; Halasz M; Jankevicius G; Bucca G; Ahel M; Matić I; Ćetković H; Luić M; Mikoč A; Ahel I
    J Biol Chem; 2016 Oct; 291(44):23175-23187. PubMed ID: 27634042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ELTA: Enzymatic Labeling of Terminal ADP-Ribose.
    Ando Y; Elkayam E; McPherson RL; Dasovich M; Cheng SJ; Voorneveld J; Filippov DV; Ong SE; Joshua-Tor L; Leung AKL
    Mol Cell; 2019 Feb; 73(4):845-856.e5. PubMed ID: 30712989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding Adaptation of GS-441524 Diversifies Macro Domains and Downregulates SARS-CoV-2 de-MARylation Capacity.
    Tsika AC; Gallo A; Fourkiotis NK; Argyriou AI; Sreeramulu S; Löhr F; Rogov VV; Richter C; Linhard V; Gande SL; Altincekic N; Krishnathas R; Elamri I; Schwalbe H; Wollenhaupt J; Weiss MS; Spyroulias GA
    J Mol Biol; 2022 Aug; 434(16):167720. PubMed ID: 35839840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and analysis of ADP-ribosylated proteins.
    Haag F; Buck F
    Curr Top Microbiol Immunol; 2015; 384():33-50. PubMed ID: 25113886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Promise of Proteomics for the Study of ADP-Ribosylation.
    Daniels CM; Ong SE; Leung AK
    Mol Cell; 2015 Jun; 58(6):911-24. PubMed ID: 26091340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of ADP-Ribosylation of the Androgen Receptor Using the Recombinant Macrodomain AF1521 from Archaeoglobus fulgidus.
    Kamata T; Yang CS; Jividen K; Spencer A; Dworak N; Oostdyk LT; Paschal BM
    Methods Mol Biol; 2019; 1966():107-124. PubMed ID: 31041742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.